Dr. David S. Schrump is the Surgical Chief of the Thoracic Surgery Branch of the National Cancer Institute’s Center for Cancer Research. In this role, he oversees clinical and translational research on thoracic malignancies, particularly lung cancers, esophageal cancers, and pleural mesotheliomas. Education and Career Dr. Schrump graduated from the University of Connecticut School of
Dr. Evan S. K. Ong is a general surgeon and surgical oncologist at the Swedish Medical Center in Seattle, Washington. He specializes in the use of state-of-the-art surgical techniques, including minimally invasive and robotic surgery for hepatic and pancreatic tumors, hyperthermic intraperitoneal chemoperfusion (HIPEC) for peritoneal mesothelioma, and microwave and bipolar radiofrequency ablation. Education and
Dr. Mark Richard Dylewski is a thoracic surgeon at the Baptist Health South Florida and its affiliated Miami Cancer Institute in Miami, Florida. He holds the titles of Chairman of Thoracic Surgery and Director of Robotic Thoracic Surgery at Baptist Health South Florida and Chief of Thoracic Surgery at Miami Cancer Institute. Education and Career
Dr. Gary M. Hochheiser is the Director of Thoracic Surgery and Thoracic Oncology at Maine Medical Center and the Medical Director for the facility’s Lung Screening Program. He specializes in the use of minimally invasive procedures for the treatment of malignant pleural mesothelioma, lung cancer, and esophageal cancer, as well as benign thoracic diseases. He
Dr. Anthony R. Lanfranco is an interventional pulmonologist and critical care specialist at Penn Medicine in Philadelphia. He specializes in numerous procedures integral to the care of patients with malignant pleural mesothelioma, lung cancer, and other pleural and lung diseases, including airway stenting, bronchial stenosis, bronchoscopy, cryotherapy, endoscopic lung volume reduction, and laser bronchoscopy. Education
Dr. Pettiford is a surgical oncologist with a focus on thoracic surgery at Ochsner M.D. Anderson Cancer Center in New Orleans, Louisiana. He has extensive experience in the treatment of malignant pleural mesothelioma and the use of robotic surgery for the treatment of lung cancer, benign lung disease, and esophageal cancer as well as benign
For decades, the world has understood asbestos’ role in the development of malignant mesothelioma, lung cancer, and other diseases. Despite this universal knowledge and countless people facing the realities of these painful asbestos-related illnesses, profit-focused companies continue defying protective regulations for asbestos management. In response to one such case, the attorney general of Massachusetts has
Dr. Borghaei is a medical oncologist and specialist in the treatment of lung cancer and malignant pleural mesothelioma at Fox Chase Cancer Center in Philadelphia, Pennsylvania. He holds the positions of Chief of Thoracic Medical Oncology, Professor in The Department of Hematology/Oncology at Fox Chase Cancer Center, and the Gloria and Edmund M. Dunn Chair
Dr. Christian Rolfo is a noted medical oncologist and specialist in the treatment of malignant pleural mesothelioma and lung cancer. He holds the title of director of the Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center – James in Columbus, Ohio . Dr. Rolfo’s care is centered around the use of
A combination of two immunotherapy drugs delivered an “encouraging” response rate in patients with advanced solid tumors, offering new hope for improvement in mesothelioma treatments. The clinical trial revealed a 37.7% objective response to treatment with anti-CTLA-4 human immunoglobulin (Ig) G1 monoclonal antibody CS1002 and the anti-PD-1 humanized recombinant IgG4 monoclonal antibody CS1003, also known